Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > Endohedral Fullerene $167,000,000/gram

<< Previous

Bullboard Posts

Next >>

Comment by postie1on Jun 07, 2024 3:14pm

111 Views

Post# 36078261

RE:RE:RE:RE:Endohedral Fullerene $167,000,000/gram

Well, I guess the fact that it was BMO who sold down on small volume and it BMO that ran it back up on bigger volume(over 300,000 at this moment) kind of backs you up. Shake that tree is what the pros' do. Volume of sells built and trigger pulled without moving price from original. That being said I wonder if that 300,000 sell order(s) were blocks.

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (Nov. 22, 2024)